GORE EXCLUDER AAA Endoprosthesis with C3 Delivery RMT231418Recalls & reported problems
W. L. Gore & Associates, Inc. · Class 3 · Implant
All models of GORE EXCLUDER AAA Endoprosthesis with C3 Delivery (51)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00733132610570), received between Aug 7, 2018 and Nov 23, 2021 — classified as 4 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).
2 other recalls cover devices cleared under the same FDA submission (P020004); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Insufficient Device Problem Information1
- Obstruction of Flow1
Patient problems
- Aneurysm2
- No Known Impact Or Consequence To Patient1
- Occlusion1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryNov 23, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT (B)(6) 2014, THE PATIENT PRESENTED WITH AN ABDOMINAL AORTIC ANEURYSM THAT WAS TREATED WITH GORE® EXCLUDER® AAA ENDOPROSTHESIS (PRE-IMPLANT CT DIAMETER 47 MM). ON (B)(6) 2015 A TYPE II ENDOLEAK WAS IDENTIFIED (CT DIAMETER 47 MM). ON (B)(6) 2021, THE ENDOLEAK WAS TREATED WITH CT GUIDED PERCUTANEOUS EMBOLIZATION ((B)(6)2021 CT DIAMETER: 51 MM). THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Aneurysm
MAUDE report 12859269 ↗InjuryApr 13, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2013, THE PATIENT WAS IMPLANTED WITH A GORE® EXCLUDER® AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON AN UNKNOWN DATE, A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN REPORTEDLY REVEALED A TYPE II ENDOLEAK WITH ANEURYSM SAC ENLARGEMENT. ON (B)(6) 2020, THERE WAS A REINTERVENTION AND THE PHYSICIAN COILED SEVERAL ACCESSORY ARTERIES THEN IMPLANTED A GORE® EXCLUDER® AAA CONTRALATERAL LEG ENDOPROSTHESIS IN THE RIGHT COMMON ILIAC ARTERY TO EXTEND THE ALREADY IMPLANTED DEVICE. THE PATIENT TOLERATED THE REINTERVENTION PROCEDURE.
Patient problems: Aneurysm
MAUDE report 9954730 ↗InjuryNov 5, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
ON (B)(6) 2013, THE PATIENT WAS IMPLANTED WITH A GORE® EXCLUDER® AAA ENDOPROSTHESIS TO TREAT AN ABDOMINAL AORTIC ANEURYSM. ON (B)(6) 2017, A FOLLOW-UP COMPUTED TOMOGRAPHY (CT) SCAN REPORTEDLY REVEALED A SUSPECTED PROXIMAL TYPE I ENDOLEAK. ON (B)(6) 2018, A FOLLOW-UP CT SCAN REPORTED SHOWED THE SAME SUSPECTED TYPE I ENDOLEAK CONTRIBUTING TO ANEURYSM ENLARGEMENT. ON (B)(6) 2018, THE PATIENT UNDERWENT A RE-INTERVENTION PROCEDURE WHEREBY AN EXCLUDER® AORTIC EXTENDER COMPONENT WAS IMPLANTED TO TREAT THE TYPE I ENDOLEAK. AN INTRA-OPERATIVE ANGIOGRAM REPORTEDLY SHOWED THE ENDOLEAK WAS NOT COMPLETELY RESOLVED. THE PHYSICIAN THEN IMPLANTED A PALMAZ STENT PROXIMALLY, AND THE ENDOLEAK WAS RESOLVED. THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8038833 ↗InjuryAug 7, 2018Obstruction of Flow; Obstruction of Flow
THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2012, THE PATIENT PRESENTED WITH AN ABDOMINAL AORTIC ANEURYSM THAT WAS TREATED WITH THE IMPLANTATION OF GORE® EXCLUDER® AAA ENDOPROSTHESES. ON (B)(6) 2018, FOLLOW-UP CT AND ULTRASOUND IMAGING SHOWED DEVICE OCCLUSION OF THE RIGHT LEG OF THE GORE® EXCLUDER® AAA ENDOPROSTHESES. IT WAS STATED THAT THE OCCLUSION WAS SUCCESSFULLY TREATED WITH THE IMPLANTATION OF AN ADDITIONAL DEVICE ON (B)(6) 2018.
Patient problems: Occlusion
MAUDE report 7756046 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P020004. One submission often covers many models, so check the product and lot details in each record.
- Z-0996-2020 · Jan 6, 2020 · TerminatedGORE EXCLUDER Iliac Branch Endoprosthesis (IBE)
- Z-0995-2020 · Jan 6, 2020 · TerminatedGORE EXCLUDER AAA Endoprosthesis
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page